Ann: Commercial Update and Regulatory Progress, page-65

First 65 Last

Share
Profile

Follow
Director12

25,970 Posts.

48

26/03/25

15:04

Post #: 78424749
Share

Originally posted by chuk: ↑

I haven't bought for a while due to it trending down relentlessly but today it has reached a share price within 2c of where it traded on the day it listed.
That's despite very positive trial results proving it works better than any other product on the market. Something that was not proven at the time of listing.
They also now have a clear path to what is needed for FDA approval and importantly they also have now have access to pre FDA sales into the US. That will be a much larger market than the Australian pre approval market. So while it appears FDA approval has been pushed out by probably at least 6 months, much of the risk has been removed and the sp is no longer near $2 but back to where it was on listing.
For those reasons, I bought another 40,000 shares today for under $20k. By comparison, 40,000 shares near the high would have cost over $80k.
Happy to buy here and sit.

Expand

Didn't it launch at 20c?

LTP Price at posting: 45.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 65 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 28.5¢		Change -0.005(1.72%)		Mkt cap ! $32.46M

Open	High	Low	Value	Volume
29.0¢	29.5¢	28.5¢	$37.1K	127.8K

Buyers (Bids)

No.	Vol.	Price($)
2	15919	28.5¢

Sellers (Offers)

Price($)	Vol.	No.
29.5¢	53854	3

View Market Depth

No.	Vol.	Price($)
2	15919	0.285
5	136148	0.280
7	174474	0.275
14	233233	0.270
7	85582	0.265

Price($)	Vol.	No.
0.295	53854	3
0.300	44092	3
0.305	1495	1
0.310	17286	2
0.315	9460	1

Last trade - 12.57pm 27/06/2025 (20 minute delay)

LTP (ASX) Chart

Ann: Commercial Update and Regulatory Progress, page-65

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Commercial Update and Regulatory Progress, page-65

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News